Advantages and disadvantages of femoral port systems in hematоlogical patients with superior vena cava syndrome | Galstyan | Russian journal of hematology and transfusiology

Russian journal of hematology and transfusiology
Gematologiâ i transfuziologiâ

ISSN 0234-5730 (Print)
ISSN 2411-3042 (Online)

eng | рус

Preview

Russian journal of hematology and transfusiology

Advanced search

Archives

Download this PDF file

For citations:

Galstyan G.M., Spirin M.V., Drokov M.Yu., Kostina I.E., Mangasarova Ya.K. Advantages and disadvantages of femoral port systems in hematоlogical patients with superior vena cava syndrome. Russian journal of hematology and transfusiology. 2020;65(4):403-416. (In Russ.) https://doi.org/10.35754/0234-5730-2020-65-4-403-416

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 0234-5730 (Print)
ISSN 2411-3042 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Elena N. Parovichnikova

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

G. M. Galstyan
National Research Center for Hematology
Russian Federation

Gennadiy M. Galstyan, Dr. Sci. (Med.), Head of the Department of Resuscitation and Intensive Care

125167, Moscow

M. V. Spirin
National Research Center for Hematology
Russian Federation

Mikhail V. Spirin, Cand. Sci. (Med.), Physician, Department of Resuscitation and Intensive Care

125167, Moscow

M. Yu. Drokov
National Research Center for Hematology
Russian Federation

Mikhail Yu. Drokov, Cand. Sci. (Med.), Head of the Department of Immunotherapy and Post-BMT Complications

125167, Moscow

I. E. Kostina
National Research Center for Hematology
Russian Federation

Irina E. Kostina, Cand. Sci. (Med.), Head of the Department of X-ray and Computer Tomography

125167, Moscow

Ya. K. Mangasarova
National Research Center for Hematology
Russian Federation

Yana K. Mangasarova, Cand. Sci. (Med.), Head of the Day Hospital at the Department of High-Dose Chemotherapy

125167, Moscow

Notifications